Drugs / Carboplatin AUC
last change Sep 2025 re-read 3 minutes ago

Carboplatin AUC

Developed for
non-small cell lung carcinoma
Investigated by
Washington University School of Medicine

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03916419 Jun 2019 → Sep 2025 non-small cell lung carcinoma Washington University School of Medicine Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Carboplatin AUC ClinicalTrials.gov intervention name — accepted as the source's own label NCT03916419 ↗